Your browser doesn't support javascript.
loading
Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipients.
Sesques, Pierre; Bachy, Emmanuel; Ferrant, Emmanuelle; Safar, Violaine; Gossez, Morgane; Morfin-Sherpa, Florence; Venet, Fabienne; Ader, Florence.
Affiliation
  • Sesques P; Lyon University Hospital, Lyon, France.
  • Bachy E; Lyon University Hospital, Lyon, France.
  • Ferrant E; Lyon University Hospital, Lyon, France.
  • Safar V; Lyon University Hospital, Lyon, France.
  • Gossez M; Lyon University Hospital, Lyon, France.
  • Morfin-Sherpa F; Lyon University Hospital, Lyon, France.
  • Venet F; Lyon University Hospital, Lyon, France.
  • Ader F; Lyon University Hospital, Lyon, France. Electronic address: florence.ader@chu-lyon.fr.
Cancer Cell ; 40(3): 236-237, 2022 03 14.
Article in En | MEDLINE | ID: mdl-35093212

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Immunotherapy, Adoptive / Antigens, CD19 / Receptors, Chimeric Antigen / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Observational_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Cell Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Immunotherapy, Adoptive / Antigens, CD19 / Receptors, Chimeric Antigen / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Observational_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Cell Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication: